0001209191-12-016267.txt : 20120306
0001209191-12-016267.hdr.sgml : 20120306
20120306190311
ACCESSION NUMBER: 0001209191-12-016267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120305
FILED AS OF DATE: 20120306
DATE AS OF CHANGE: 20120306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIDA ANTHONY E III
CENTRAL INDEX KEY: 0001273213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 12672045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-03-05
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001273213
MAIDA ANTHONY E III
11500 S. EASTERN AVE.
SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock
2012-03-05
4
M
0
3200
2.55
A
5450
D
Common Stock
2012-03-05
4
S
0
3200
12.83
D
2250
D
Common Stock
2012-03-06
4
M
0
2500
2.55
A
4750
D
Common Stock
2012-03-06
4
S
0
2500
12.70
D
2250
D
Stock Option Exercise (Right to Buy)
2.55
2012-03-05
4
M
0
3200
0.00
D
2018-03-25
Common Stock
3200
5800
D
Stock Option Exercise (Right to Buy)
2.55
2012-03-06
4
M
0
2500
0.00
D
2018-03-25
Common Stock
2500
3300
D
The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on March 25, 2008. The stock option became exercisable as to 50% of the underlying shares on the grant date, and became exercisable as to the remaining shares in equal monthly installments over the one year period following the grant date.
/s/ Shyam Kumaria, attorney-in-fact for Anthony E. Maida
2012-03-06
EX-24.4_414690
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
AUTHORIZATION
I hereby authorize Rajesh C. Shrotriya, M.D. or Shyam Kumaria, acting singly, to
sign and file on my behalf any and all forms required by the Securities and
Exchange Commission pursuant to Section 16 of the Securities Exchange Act of
1934 (the "Exchange Act") relating to the reporting of beneficial ownership of
equity securities of Spectrum Pharmaceuticals, Inc., a Delaware corporation (the
"Company"), and of changes in such beneficial ownership, together with any and
all amendments thereto. This authorization shall be effective on and after the
date set forth below and shall continue in effect until I am no longer required
to file such forms, unless earlier revoked by me in writing.
I acknowledge that the persons authorized hereunder are not assuming,
nor is the Company assuming, any of my responsibilities to comply with
Section 16 of the Exchange Act.
Dated as of this 12th day of December, 2003.
/s/ Anthony E. Maida
Anthony E. Maida